Dimensional Fund Advisors LP Taro Pharmaceutical Industries LTD Transaction History

Dimensional Fund Advisors LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$40.97 - $43.33 $1.07 Million - $1.13 Million	-25,998 Reduced 4.76%	519,684 $22 Million
Q4 2023 Feb 07, 2024	SELL	$32.77 - $42.31 $138,486 - $178,802	-4,226 Reduced 0.77%	545,682 $22.8 Million
Q3 2023 Nov 09, 2023	SELL	$35.46 - $40.13 $79,926 - $90,453	-2,254 Reduced 0.41%	549,908 $20.7 Million
Q2 2023 Aug 09, 2023	SELL	$24.24 - $40.97 $502,810 - $849,840	-20,743 Reduced 3.62%	552,162 $20.9 Million
Q1 2023 May 12, 2023	BUY	$23.0 - $31.59 $58,305 - $80,080	2,535 Added 0.44%	572,905 $13.9 Million
Q4 2022 Feb 09, 2023	BUY	$27.6 - $32.99 $87,630 - $104,743	3,175 Added 0.56%	570,370 $16.6 Million
Q3 2022 Nov 10, 2022	BUY	$28.74 - $39.9 $332,866 - $462,121	11,582 Added 2.08%	567,195 $17 Million
Q2 2022 Aug 12, 2022	BUY	$35.0 - $43.59 $734,440 - $914,692	20,984 Added 3.92%	555,613 $20.1 Million
Q1 2022 May 13, 2022	BUY	$43.12 - $50.3 $773,874 - $902,734	17,947 Added 3.47%	534,629 $23.1 Million
Q4 2021 Feb 09, 2022	SELL	$47.6 - $65.0 $287,075 - $392,015	-6,031 Reduced 1.15%	516,682 $25.9 Million
Q3 2021 Nov 12, 2021	BUY	$62.34 - $73.38 $41,954 - $49,384	673 Added 0.13%	522,713 $33.3 Million
Q2 2021 Aug 12, 2021	BUY	$70.26 - $76.64 $1.37 Million - $1.5 Million	19,547 Added 3.89%	522,040 $37.6 Million
Q1 2021 May 14, 2021	BUY	$70.48 - $79.95 $1.66 Million - $1.88 Million	23,499 Added 4.91%	502,493 $37.1 Million
Q4 2020 Feb 25, 2021	BUY	$54.4 - $73.42 $26.1 Million - $35.2 Million	478,994 New	478,994 $35.2 Million

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.